Compound 864
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)S(N)(=O)=O)c1=O
- IUPAC name:
4-[6-methyl-3-oxo-4-[3-(trifluoromethyl)phenyl]-1H-dipyrazolo[4,3-b:4',5'-e]pyridin-2-yl]benzenesulfonamide
- InChi:
InChI=1S/C21H15F3N6O3S/c1-29-19-15(10-26-29)18-16(17(27-19)11-3-2-4-12(9-11)21(22,23)24)20(31)30(28-18)13-5-7-14(8-6-13)34(25,32)33/h2-10,28H,1H3,(H2,25,32,33)
- InChiKey:
HYXMPCIQSWHPTK-UHFFFAOYSA-N
External links
12096159 |
11591252 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.82 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 488.09 g/mol | |||
HBA | 9 | |||
HBD | 3 | |||
HBA + HBD | 12 | |||
AlogP | 3.60 | |||
TPSA | 123.21 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5048 | 1-[4-(AMINOSULFONYL)PHENYL]-1,6-DIHYDROPYRAZOLO[3,4-E]INDAZOLE-3-CARBOXAMIDE | DB08527 | |
0.4930 | SC-236 | DB14059 | |
0.4832 | Celecoxib | DB00482 | |
0.4753 | Deracoxib | DB11395 | |
0.4673 | 1-Phenylsulfonamide-3-Trifluoromethyl-5-Parabromophenylpyrazole | DB03477 | |
0.4573 | ATX-914 | DB12673 | |
0.4498 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4480 | Riociguat | DB08931 | |
0.4380 | Tepotinib | DB15133 | |
0.4346 | Rilematovir | DB15672 | |
0.4341 | Vericiguat | DB15456 | |
0.4340 | Decoglurant | DB11923 | |
0.4320 | Apricoxib | DB12378 | |
0.4280 | Dilmapimod | DB12140 | |
0.4254 | Risdiplam | DB15305 |